Abstract
Introduction
Bariatric surgery is the most effective modality to stably reduce weight and related comorbidities in patients suffering from class II and III obesity. Data comparing long-term safety and efficacy of the three most effective bariatric operations are limited in patients with BMI ≥ 50 kg/m2, which complicate shared surgeon–patient decision making regarding optimal procedure selection.
Methods
A retrospective analysis was performed on all patients with BMI ≥ 50 kg/m2 who underwent biliopancreatic diversion with duodenal switch (BPD/DS), Roux-en-Y gastric bypass (RYGB), or sleeve gastrectomy (SG) at our institution between 2009 and 2019. Data collected from patients’ electronic medical records included operative details as well as BMI and presence and resolution of obesity-related comorbidities at 0, 6, 12, 24, 48, and 60 months post-operatively.
Results
Among 537 patients with BMI ≥ 50 kg/m2 who had a primary bariatric procedure, 93 patients underwent BPD/DS (17.3%), 341 patients underwent RYGB (63.5%), and 103 patients underwent SG (19.2%). BMI decreased by 23.7 kg/m2 in BPD/DS, 14.7 kg/m2 in RYGB, and 13.6 kg/m2 in SG cohorts at 60 months post-operatively (p < 0.0001). The greatest %TWL occurred in BPD/DS cohort (38.4%) followed by the RYGB (26.3%) and SG (23.6%) cohorts (p < 0.0001). The thirty-day complication rate was 12.9% for BPD/DS, 4.7% for RYGB, and 8.7% for SG (p = 0.015).
Conclusions
Our study demonstrated that the BPD/DS is the most effective operation at long-term reduction of BMI and achieved highest %TWL while SG and RYGB had similar results at 60 months post-op. BPD/DS is associated with increased early and late surgical complications compared to RYGB and SG.
Similar content being viewed by others
References
Abd El Aziz MA et al (2020) Colectomy for patients with super obesity: current practice and surgical morbidity in the United States. Surg Obes Relat Dis 16(11):1764–1769
Stephens DJ et al (2008) Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. Surg Obes Relat Dis 4(3):408–415
Cardoso L et al (2017) Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab 19(9):1223–1232
English WJ et al (2020) American Society for metabolic and bariatric surgery 2018 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis 16(4):457–463
Ding L et al (2020) Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials. Obes Rev 21(8):e13030
Hedberg J, Sundstrom J, Sundbom M (2014) Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons. Obes Rev 15(7):555–563
Samuel N et al (2020) Mid-term bariatric surgery outcomes for obese patients: does weight matter? Ann R Coll Surg Engl 102(1):54–61
Topart P, Becouarn G, Ritz P (2012) Comparative early outcomes of three laparoscopic bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 8(3):250–254
Lee Y et al (2019) Bridging interventions before bariatric surgery in patients with BMI >/= 50 kg/m(2): a systematic review and meta-analysis. Surg Endosc 33(11):3578–3588
Uno K et al (2017) A comparison of the bariatric procedures that are performed in the treatment of super morbid obesity. Obes Surg 27(10):2537–2545
Wang Y et al (2019) Roux-en-Y Gastric bypass versus sleeve gastrectomy for super super obese and super obese: systematic review and meta-analysis of weight results, comorbidity resolution. Obes Surg 29(6):1954–1964
Sovik TT et al (2010) Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg 97(2):160–166
Park CH et al (2019) Comparative efficacy of bariatric surgery in the treatment of morbid obesity and diabetes mellitus: a systematic review and network meta-analysis. Obes Surg 29(7):2180–2190
Prachand VN, Davee RT, Alverdy JC (2006) Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass. Ann Surg 244(4):611–619
Roth AE, Thornley CJ, Blackstone RP (2020) Outcomes in bariatric and metabolic surgery: an updated 5-year review. Curr Obes Rep 9(3):380–389
Bettencourt-Silva R et al (2019) Comparative effectiveness of different bariatric procedures in super morbid obesity. Obes Surg 29(1):281–291
Celio AC et al (2017) Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients. Surg Endosc 31(1):317–323
Arapis K et al (2019) Outcomes of Roux-en-Y gastric bypass versus sleeve gastrectomy in super-super-obese patients (BMI >/=60 kg/m(2)): 6-year follow-up at a single university. Surg Obes Relat Dis 15(1):23–33
Artero A et al (2017) Anthropometric parameters and permanent remission of comorbidities 10 years after open gastric bypass in a cohort with high prevalence of super-obesity. Endocrinol Diabetes Nutr 64(6):310–316
Peterson K et al (2017) Rapid evidence review of bariatric surgery in super obesity (BMI >/= 50 kg/m(2)). J Gen Intern Med 32(Suppl 1):56–64
Shoar S, Saber AA (2017) Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Relat Dis 13(2):170–180
Magro DO et al (2018) Long-term weight loss outcomes after banded Roux-en-Y gastric bypass: a prospective 10-year follow-up study. Surg Obes Relat Dis 14(7):910–917
Sovik TT et al (2011) Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med 155(5):281–291
Risstad H et al (2015) Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial. JAMA Surg 150(4):352–361
Gronroos S et al (2021) Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss and quality of life at 7 years in patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg 156(2):137–146
Nelson DW, Blair KS, Martin MJ (2012) Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Arch Surg 147(9):847–854
Sada A et al (2020) Outcomes of duodenal switch with a moderate common channel length and Roux-en-y Gastric bypass: does one pose more risk? Obes Surg 30(8):2870–2876
Gumbs AA et al (2007) Sleeve gastrectomy for morbid obesity. Obes Surg 17(7):962–969
Shi X et al (2010) A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg 20(8):1171–1177
Frezza EE et al (2009) Complications after sleeve gastrectomy for morbid obesity. Obes Surg 19(6):684–687
Courcoulas A et al (2020) Interventions and operations 5 years after bariatric surgery in a cohort from the US national patient-centered clinical research network bariatric study. JAMA Surg 155(3):194–204
Harris LA et al (2019) Biliopancreatic diversion induces greater metabolic improvement than Roux-en-Y gastric bypass. Cell Metab 30(5):855–864
Michaud A et al (2017) Biliopancreatic diversion with duodenal switch leads to better postprandial glucose level and beta cell function than sleeve gastrectomy in individuals with type 2 diabetes very early after surgery. Metabolism 74:10–21
Sudan R, Jain-Spangler K (2018) Tailoring bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. J Laparoendosc Adv Surg Tech A 28(8):956–961
Carswell KA et al (2016) A systematic review and meta-analysis of the effect of gastric bypass surgery on plasma lipid levels. Obes Surg 26(4):843–855
Liaskos C et al (2018) Roux-en-Y gastric bypass is more effective than sleeve gastrectomy in improving postprandial glycaemia and lipaemia in non-diabetic morbidly obese patients: a short-term follow-up analysis. Obes Surg 28(12):3997–4005
Van Osdol AD et al (2017) Impact of laparoscopic Roux-en-Y Gastric bypass versus sleeve gastrectomy on postoperative lipid values. Surg Obes Relat Dis 13(3):399–403
Climent E et al (2018) Changes in the lipid profile 5 years after bariatric surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 14(8):1099–1105
Du X et al (2018) Resolution of metabolic syndrome and related metabolic disorders after bariatric surgery: comparison of sleeve gastrectomy and gastric bypass. Surg Obes Relat Dis 14(9):1348–1356
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Mr. Justin Maroun and Mr. Mark Li have no conflict of interest or financial ties to disclose. Drs. Omobolanle Oyefule, Joseph El Badaoui, Travis McKenzie, Michael Kendrick, Todd Kellogg and Omar Ghanem have no conflict of interest or financial ties to disclose.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of and was approved by the Institutional Review Board, and for this type of retrospective study, formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Maroun, J., Li, M., Oyefule, O. et al. Ten year comparative analysis of sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch in patients with BMI ≥ 50 kg/m2. Surg Endosc 36, 4946–4955 (2022). https://doi.org/10.1007/s00464-021-08850-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-021-08850-y